There are mainly 2 method to prepare spiro-OMeTAD reported in research article  based on the perovskite solar cell.

Method-1

180mg of 2,2′,7,7′-tetrakis-(N,N-di-p-methoxyphenyl-amine)-9,9′-spirobifluorene(spiro-MeOTAD, Merck, KGaA Darmstadt, Germany) was dissolved in 1ml of chlorobenzene (99.8%, Aldrich) with the addition of 37.5 μl bis (trifiuoromethane)sulfonimide lithium salt (LiTFSI, 99.95%, Aldrich)

(170mg ml− 1) in acetonitrile and 17.5 μl 4-tert-butylpyridine (96%, Aldrich).

Method-2

2,2ˊ,7,7ˊ-tetrakis(N,N-di-p-methoxyphenylamine)-9,9-spirobifluorene (spiro-OMeTAD, Merck, 72.3 mg) in anhydrous chlorobenzene (CB, 99.8%,

Sigma–Aldrich, 1.0 mL) containing 28.8 μL of 4-tert-butylpyridine (Aldrich) and 17.5 μL of lithium bis(trifluoromethanesulfonyl)imide (Li-TFSI) solution (520 mg Li-TFSI in 1 mL acetonitrile, Sigma–Aldrich).

I am confused between this 2 method.

please suggest me which is the best method for spiro-OMeTAD.

More Rohit Chavan's questions See All
Similar questions and discussions